Apex Healthcare Bhd - Asset Resilience Ratio
Apex Healthcare Bhd (7090) has an Asset Resilience Ratio of 22.35% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2012–2024)
This chart shows how Apex Healthcare Bhd's Asset Resilience Ratio has changed over time. Check 7090 strategic asset allocation to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Apex Healthcare Bhd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Apex Healthcare Bhd.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | RM227.62 Million | 22.35% |
| Short-term Investments | RM0.00 | 0% |
| Total Liquid Assets | RM227.62 Million | 22.35% |
Asset Resilience Insights
- Good Liquidity Position: Apex Healthcare Bhd maintains a healthy 22.35% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Apex Healthcare Bhd Industry Peers by Asset Resilience Ratio
Compare Apex Healthcare Bhd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Selcuk Ecza Deposu Ticaret ve Sanayi AS
IS:SELEC |
Medical Distribution | 5.70% |
|
Sigma Healthcare Ltd
AU:SIG |
Medical Distribution | 0.03% |
|
Ebos Group Ltd
AU:EBO |
Medical Distribution | 0.00% |
|
Paragon Care Ltd
AU:PGC |
Medical Distribution | 0.00% |
|
Mayne Pharma Group Ltd
AU:MYX |
Medical Distribution | 4.00% |
|
Cyclopharm Ltd
AU:CYC |
Medical Distribution | 1.98% |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3 |
Medical Distribution | 4.48% |
|
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607 |
Medical Distribution | 4.21% |
Annual Asset Resilience Ratio for Apex Healthcare Bhd (2012–2024)
The table below shows the annual Asset Resilience Ratio data for Apex Healthcare Bhd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.53% | RM5.34 Million ≈ $1.34 Million |
RM1.01 Billion ≈ $253.30 Million |
-25.84pp |
| 2023-12-31 | 26.37% | RM296.05 Million ≈ $74.33 Million |
RM1.12 Billion ≈ $281.85 Million |
-6.33pp |
| 2022-12-31 | 32.70% | RM243.73 Million ≈ $61.19 Million |
RM745.26 Million ≈ $187.11 Million |
+17.90pp |
| 2021-12-31 | 14.81% | RM100.70 Million ≈ $25.28 Million |
RM680.14 Million ≈ $170.76 Million |
+0.30pp |
| 2020-12-31 | 14.51% | RM90.10 Million ≈ $22.62 Million |
RM620.92 Million ≈ $155.89 Million |
+5.66pp |
| 2019-12-31 | 8.85% | RM51.59 Million ≈ $12.95 Million |
RM583.17 Million ≈ $146.41 Million |
+4.19pp |
| 2018-12-31 | 4.66% | RM25.15 Million ≈ $6.31 Million |
RM539.97 Million ≈ $135.57 Million |
-2.89pp |
| 2017-12-31 | 7.55% | RM34.49 Million ≈ $8.66 Million |
RM456.90 Million ≈ $114.71 Million |
-3.89pp |
| 2016-12-31 | 11.44% | RM47.88 Million ≈ $12.02 Million |
RM418.41 Million ≈ $105.05 Million |
+10.67pp |
| 2015-12-31 | 0.77% | RM3.00 Million ≈ $753.20K |
RM390.00 Million ≈ $97.92 Million |
+0.20pp |
| 2014-12-31 | 0.56% | RM2.00 Million ≈ $502.13K |
RM354.00 Million ≈ $88.88 Million |
-1.35pp |
| 2013-12-31 | 1.92% | RM6.00 Million ≈ $1.51 Million |
RM313.00 Million ≈ $78.58 Million |
-7.05pp |
| 2012-12-31 | 8.97% | RM26.00 Million ≈ $6.53 Million |
RM290.00 Million ≈ $72.81 Million |
-- |
About Apex Healthcare Bhd
Apex Healthcare Berhad, an investment holding company, engages in the development, manufacture, marketing, distribution, and wholesale of pharmaceutical and healthcare products in Malaysia, Singapore, and internationally. It operates in three segments: Manufacturing, Distribution, and Corporate. The company offers a range of products, including cough mixture and antihistamine, anti-infective, ant… Read more